Remedium Bio Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Remedium Bio is a biotechnology company developing gene therapies for conditions with substantial unmet clinical need. It has built a platform that enables safe, durable delivery of therapeutic genes and supports post-treatment dose adjustment. Its lead program targets osteoarthritis with a disease-modifying approach based on a clinically validated chondro-regenerative mechanism. The company aims for single-treatment options that can replace multi-injection biologics, at a fraction of the cost and without genetic integration. Based in Needham, Massachusetts, Remedium Bio operates in the biotechnology research sector with a pipeline that includes gene therapies targeting obesity, Type 2 Diabetes, and stroke. In 2025, the company announced a strategic collaboration with Lilly to advance gene therapies for obesity and Type 2 Diabetes.